How long should you take Upadacitinib extended-release tablets for a course of treatment?

The duration of a course of Upadacitinib (Upadacitinib) varies between individuals, and the specific duration depends on the patient's condition, age, weight and other factors. Generally speaking, upadatinib needs to be taken continuously for a period of time until the condition is controlled or symptoms are significantly improved. Because this is a long-term treatment, it's important to keep taking upadacitin (unless the patient has severe side effects) even if it doesn't seem to be working at first, or even if symptoms improve. Upadatinib is not a pain reliever, but it can reduce symptoms and limit joint damage that may be caused by a patient's condition. If upadatinib is effective, symptoms may improve within 2 to 8 weeks after starting it, but the full benefit may not be noticed for 3 to 6 months.